PLSH (Panacea Life Sciences Holdings) Net Income: $0.79 Mil (TTM As of Sep. 2025)


PLSH Panacea Life Sciences Holdings Inc PLSH
26 GF Score
Price $0.13
! 6 Warning Signs
View Full Analysis

What is Panacea Life Sciences Holdings Net Income?

Panacea Life Sciences Holdings PLSH +17.02% 26 Net Income is $0.79 Mil as of Sep. 2025. GuruFocus rates PLSH with a GF Score™ of 26/100. The stock has 6 warning signs investors should review.

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax. Panacea Life Sciences Holdings's Net Income for the three months ended in Sep. 2025 was $-0.18 Mil. Its Net Income for the trailing twelve months (TTM) ended in Sep. 2025 was $0.79 Mil.

Net Income is linked to the most popular Earnings per Share (Diluted) number. Panacea Life Sciences Holdings's Earnings per Share (Diluted) for the three months ended in Sep. 2025 was $-0.00.


Panacea Life Sciences Holdings  (OTCPK:PLSH) Net Income Explanation

Net Income is the most widely cited number in reporting a company's profitability. It is linked to the most popular earnings-per-share (EPS) number through:

Panacea Life Sciences Holdings's Earnings per Share (Diluted) (EPS) for the quarter that ended in Sep. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

EPS is most useful for companies that have:

A predictable business
Consistent accounting methods
And few restructurings

The dividend paid to preferred stocks needs to be subtracted from the total net income in the calculation of EPS because common stock holders are not entitled to that part of the net income.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred Net Income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Panacea Life Sciences Holdings Net Income Related Terms


Panacea Life Sciences Holdings Net Income Historical Data

* Premium members only.

The historical data trend for Panacea Life Sciences Holdings's Net Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Panacea Life Sciences Holdings Net Income Chart

Panacea Life Sciences Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Net Income
-5.23 -4.78 -9.14 -8.02

Panacea Life Sciences Holdings Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25
Net Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.46 -1.13 -0.00 0.97 -0.18
PLSH
26GF Score
Panacea Life Sciences Holdings Inc PLSH
Net Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Panacea Life Sciences Holdings Net Income Calculation

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax.

Net Income
= Revenue - Cost of Goods Sold - Selling, General, & Admin. Expense - Research & Development - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= EBITDA - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Operating Income - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Pre-Tax Income - Tax Expense + Others

Panacea Life Sciences Holdings's Net Income for the fiscal year that ended in Dec. 2023 is calculated as

Net Income(A: Dec. 2023 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=-8.015+0+0+0
=-8.02

Panacea Life Sciences Holdings's Net Income for the quarter that ended in Sep. 2025 is calculated as

Net Income(Q: Sep. 2025 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=-0.184+0+0+0
=-0.18

Net Income for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.79 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Income →
What does a Net Income of $0.79 Mil mean?
Panacea Life Sciences Holdings (PLSH) has a Net Income of $0.79 Mil as of Sep. 2025. Net Income is the total earnings after all operating expenses, interest and taxes. View historical data on Panacea Life Sciences Holdings and its competitors.
Is Panacea Life Sciences Holdings' Net Income too high?
Panacea Life Sciences Holdings' current Net Income is $0.79 Mil. Overall, Panacea Life Sciences Holdings has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Panacea Life Sciences Holdings' Net Income compare to SKYI and IMCC?
Panacea Life Sciences Holdings' Net Income of $0.79 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Income for a Drug Manufacturers company?
A good Net Income depends on the Drug Manufacturers industry context. However, Net Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Income mean?
A high Net Income can signal that a stock is expensive relative to its fundamentals. Net Income is the total earnings after all operating expenses, interest and taxes. View historical data on Panacea Life Sciences Holdings and its competitors. Panacea Life Sciences Holdings's current Net Income is $0.79 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Panacea Life Sciences Holdings stock overvalued right now?
Panacea Life Sciences Holdings (PLSH) has a current Net Income of $0.79 Mil. The current Net Income is $0.79 Mil. Panacea Life Sciences Holdings' overall GF Score™ is 26/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Income calculated?
Net Income is calculated from a company's financial statements. For Panacea Life Sciences Holdings (PLSH), the current Net Income is $0.79 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Panacea Life Sciences Holdings Business Description

Address 5910 South University Boulevard, C18-193, Greenwood Village, CO, USA, 80121
Panacea Life Sciences Holdings Inc is a holding company organized as a plant-based natural health ingredient and product company, specializing in the development, manufacturing, research, and distribution of products and rapidly growing natural health and wellness market segment for both humans and animals. The company also offers the purest natural remedies within its branded product lines for every aspect of life: PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure and PANA Life.
26GF Score

Get the complete analysis for PLSH

Net Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.13
Price